Early follicular anti-mullerian hormone as a predictor of ovarian response during ICSI cycles

Middle East Fertility Society Journal

Volumn 15, Issue 4, 2010, Pages 281-287

  Moawad, Ashraf ^a,c   Elmawgood, Hanan Abd ^b   Shaeer, Mahmoud ^c  

^a AL AZHAR UNIVERSITY   (Egypt)

^b Al Azhar University   (Egypt)

^c IVF Unit   (United Arab Emirates)

Author keywords

Anti mullerian hormone; ICSI; Ovarian response

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; INHIBIN B; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR; RECOMBINANT FOLLITROPIN; TRIPTORELIN;

ADULT; ARTICLE; CELL COUNT; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FOLLICULAR PHASE; FOLLITROPIN BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OVARY FOLLICLE; OVARY FUNCTION; OVULATION INDUCTION; PROSPECTIVE STUDY; TRANSVAGINAL ECHOGRAPHY; TREATMENT RESPONSE;

EID: 79952817616     PISSN: 11105690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mefs.2010.07.006     Document Type: Article

References (43)

1. Kwee J, Elting MW, Schats R, Bezemer PD, Lambalk CB, Schoemarker J. Comparison of endocrine tests with respect to their predictive value on the outcome of ovarian hyperstimulation in IVF treatment: results of a prospective randomized study. Hum Reprod 2003;18:1422-7. (Pubitemid 36840948)
2. Bukulmez O, Arici A. Assessment of ovarian reserve. Curr Opin Obstet Gynecol 2004;16:231-7. (Pubitemid 38703838)
3. Jarvela IY, Sladkevicius P, Kelly S, Ojha K, Campbell S, Nargund G. Quantification of ovarian power Doppler signal with three-dimensional ultrasonography to predict response during in vitro fertilization. Obstet Gynecol 2003;102:816-22. (Pubitemid 37206419)
4. Ficicioglu C, Kutlu T, Demirbaşo?lu S, Mulayim B. The role of inhibin B as a basal determinant of ovarian reserve. Gynecol Endocrinol 2003;17:287-93.
5. Wallace WH, Kelsey TW. Ovarian reserve and reproductive age may be determined from measurement of ovarian volume by transvaginal sonography. Hum Reprod 2004;19:1612-7. (Pubitemid 38997191)
6. Hendriks DJ, Mol BW, Bancsi LF, te Velde ER, Broekmans FJ. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level. Fertil Steril 2005;83:291-301.
7. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 2006;12:685-718. (Pubitemid 44605509)
8. Jain T, Soules MR, Collins JA. Comparison of basal follicle-stimulating hormone versus the clomiphene citrate challenge test for ovarian reserve screening. Fertil Steril 2004;82:180-5. (Pubitemid 38968796)
9. te Velde ER, Pearson PL. The variability of female reproductive aging. Hum Reprod Update 2002;8:141-4.
10. Gougeon A, Echochard R, Thalabard JC. Age-related changes of the population of human ovarian follicles: increase in the disappearance rate of nongrowing and early-growing follicles in aging women. Biol Reprod 1994;50:653-63. (Pubitemid 24058526)
11. Klinkert ER, Broekmans FJ, Looman CW, te Velde ER. A poor response in the first in vitro fertilization cycle is not necessarily related to a poor prognosis in subsequent cycles. Fertil Steril 2004;81:1247-53.
12. Hendriks DJ, Kwee J, Mol BW, te Velde ER, Broekmans FJ. Ultrasonography as a tool for the prediction of outcome in IVF patients: a comparative meta-analysis of ovarian volume and antral follicle count. Fertil Steril 2007;87:764-75.
13. de Koning CH, Benjamins T, Harms P, Homburg R, van Montfrans JM, Gromoll J, et al. The distribution of FSH receptor isoforms is related to basal FSH levels in subfertile women with normal menstrual cycles. Hum Reprod 2006;21:443-6. (Pubitemid 43159920)
14. Lashen H, Ledger W, Lopez-Bernal A, Barlow D. Poor responders to ovulation induction: is proceeding to in-vitro fertilization worthwhile? Hum Reprod 1999;14:964-9.
15. van Disseldorp J, Eijkemans MJ, Klinkert ER, te Velde ER, Fauser BC, Broekmans FJ. Cumulative live birth rates following IVF in 41- to 43-year-old women presenting with favourable ovarian reserve characteristics. Reprod Biomed Online 2007;14:455-63.
16. Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, Best S, et al. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 1996;81:571-6. (Pubitemid 26055665)
17. Weenen C, Laven JS, Von Bergh AR, Cranfield M, Groome NP, Visser JA, et al. Anti-mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 2004;10:77-83. (Pubitemid 38196508)
18. Fanchin R, Schonauer LM, Righini C, Frydman N, Frydman R, Taieb J. Serum antimullerian hormone dynamics during controlled ovarian hyperstimulation. Hum Reprod 2003;18:328-32. (Pubitemid 36236266)
19. La Marca A, Malmusi S, Giulini S, Tamaro LF, Orvieto R, Levratti P, et al. Anti-mullerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation. Hum Reprod 2004;19:2738-41. (Pubitemid 40028941)
20. Cook CL, Siow Y, Taylor S, Fallat ME. Serum mullerian-inhibiting substance levels during normal menstrual cycles. Fertil Steril 2000;73:859-61. (Pubitemid 30154132)
21. Hudson PL, Dougas I, Donahoe PK, Cate RL, Epstein J, Pepinsky RB, et al. An immunoassay to detect human mullerian inhibiting substance in males and females during normal development. J Clin Endocrinol Metab 1990;70:16-22.
22. de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 2002;77:357-62. (Pubitemid 34083560)
23. van Rooij IA, Broekmans FJ, te Velde ER, Fauser BC, Bancsi LF, Jong FH, et al. Serum antimullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 2002;17:3065-71.
24. Gruijters MJ, Visser JA, Durlinger AL, Themmen AP. Anti-mullerian hormone and its role in ovarian function. Mol Cell Endocrinol 2003;211:85-90. (Pubitemid 37491239)
25. Hehenkamp WJ, Looman CW, Themmen AP, de Jong FH, te Velde ER, Broekmans FJ. Anti-mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab 2006;91:4057-63. (Pubitemid 44536885)
26. La Marca A, Stabile G, Artenisio AC, Volpe A. Serum antimullerian hormone throughout the human menstrual cycle. Hum Reprod 2006;21:3103-7. (Pubitemid 44811610)
27. Seifer DB, MacLaughlin DT, Christian BP, Feng B, Shelden RM. Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril 2002;77:468-71. (Pubitemid 34177199)
28. van Rooij IA, de Jong E, Broekmans FJ, Looman CW, Habbema JD, te Velde ER. High follicle-stimulating hormone levels should not necessarily lead to the exclusion of subfertile patients from treatment. Fertil Steril 2004;81:1478-85.
29. Hazout A, Bouchard P, Seifer DB, Aussage P, Junca AM, Cohen-Bacrie P. Serum antimullerian hormone/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Fertil Steril 2004;82:1323-9. (Pubitemid 39469455)
30. The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 2008;89(3):505-22.
31. Long WQ, Ranchin V, Pautie P, Belville C, Denizot P, Cailla H, et al. Detection of minimal levels of serum anti-mullerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay. J Clin Endocrinol Metab 2000;85:540-4. (Pubitemid 32273631)
32. Muttukrishna S, Suharjono H, McGarrigle H, Sathanandan M. Inhibin B and antimullerian hormone: markers of ovarian response in IVF/ICSI patients? BJOG 2004;111:1248-53.
33. Jurema MW, Bracero NJ, Garcia JE. Fine tuning cycle day 3 hormonal assessment of ovarian reserve improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles. Fertil Steril 2003;80:1156-61. (Pubitemid 37377743)
34. Ficicioglu C, Kutlu T, Baglam E, Bakacak Z. Early follicular antimullerian hormone as an indicator of ovarian reserve. Fertil Steril 2006;85:592-6. (Pubitemid 43261548)
35. Reuss ML, Kline J, Santos R, Levin B, Timor-Tritsch I. Age and the ovarian follicle pool assessed with transvaginal ultrasonography. Am J Obstet Gynecol 1996;174:624-7. (Pubitemid 26070154)
36. Chang MY, Chiang CH, Hsieh TT, Soong YK, Hsu KH. Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertil Steril 1998;69:505-10.
37. Laszlo FJMM, Bancsi LF, Broekmans FJ, Eijkemans MJ, de Jong FH, Habbema JD, et al. Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril 2002;77:328-36. (Pubitemid 34083557)
38. Laven JS, Mulders AG, Visser JA, Themmen AP, De Jong FH, Fauser BCJM. Anti-mullerian hormone serum concentrations in normoovulatory and anovulatory patients of reproductive age. J Clin Endocrinol Metab 2004;89:318-23. (Pubitemid 38183899)
39. Razieh Dehghani-Firouzabadi, Naeimeh Tayebi, Maryam Asgharnia. Serum level of anti-mullerian hormone in early follicular phase as a predictor of ovarian reserve and pregnancy outcome in assisted reproductive technology cycles. Arch Iranian Med 2008;11(4):371-6.
40. Bancsi LF, Broekmans FJ, Eijkemans MJ, de Jong FH, Habbema JD, te Velde ER. Predictors of poor ovarian response in in vitro fertilization (a prospective study comparing basal markers of ovarian reserve). Fertil Steril 2002;77:328-36.
41. Frattarelli JL, Levi AJ, Miller BT, Segars JH. A prospective assessment of the predictive value of basal antral follicles in in vitro fertilization. Fertil Steril 2003;80:350-5. (Pubitemid 36959793)
42. Deffieux X, Antoine JM. Inhibins, activins, and anti-mullerian hormone: structure, signaling pathways, role, and predictive value in reproductive medicine. Gynecol Obstet Fertil 2003;31:900-11.
43. Muttukrishna S, McGarrigle H, Wakim R, Khadum I, Ranieri DM, Serhal P. Antral follicle count, antimullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? BJOG 2005;112:1384-90.